Anjanajyoti Biomolecular Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2020
- Revenue %
(FY 2019)
- Profit 11.16%
(FY 2019)
- Net Worth -0.88%
(FY 2019)
- Total Assets -9.01%
(FY 2019)
About Anjanajyoti Biomolecular
The Corporate was formerly known as Knights Sports & Events Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ujjwal Handa and Nupur Prasad serve as directors at the Company.
- CIN/LLPIN
U33100DL2016PTC298466
- Company No.
298466
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2016
- Date of AGM
25 Sep 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anjanajyoti Biomolecular?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ujjwal Handa  | Director | 25-Apr-2016 | Current |
| Nupur Prasad | Director | 28-Apr-2017 | Current |
Financial Performance of Anjanajyoti Biomolecular.
Anjanajyoti Biomolecular Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 11.16% increase in profit. The company's net worth dipped by a decrease of 0.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Anjanajyoti Biomolecular?
Unlock access to Anjanajyoti Biomolecular's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Anjanajyoti Systems Private LimitedActive 4 years 11 monthsUjjwal Handa and Nupur Prasad are mutual person
- Anjanajyoti Healthtech Private LimitedActive 1 year 1 month
Ujjwal Handa and Nupur Prasad are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anjanajyoti Biomolecular?
Unlock and access historical data on people associated with Anjanajyoti Biomolecular, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anjanajyoti Biomolecular, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anjanajyoti Biomolecular's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
